Bio-Rad Laboratories | BIO - Ebit

Aktienkurs
280.12
Täglich Wechseln
4.97 1.81%
Monatlich
0.49%
Jährlich
16.75%
Q2 Prognose
281.68




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 941.3M 1.36B 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.34B 158M 2026-03
General Electric Aerospace USD 2.09B 416M 2026-03
Illumina USD 256M 6M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Laboratory Of America USD 382M 11M 2025-12
Merck USD 6.24B 1.32B 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Repligen USD 19.97M 3.16M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Siemens EUR 2.57B 3M 2025-12
Standard Biotools USD -21.92M 10.97M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Tosoh JPY 25.15B 3.51B 2025-12
Waters USD 270.52M 78.4M 2025-12